In prostate cancer patients with resistance to prostate-specific membrane antigen-targeting α-radiation therapy, BRCA1 and BRCA2 genes were deleted, and several variants of BRCA1 were detected140. The gene discussed is BRCA1; the disease is Familial prostate cancer.